Cargando…
Herceptin Resistance Database for Understanding Mechanism of Resistance in Breast Cancer Patients
Monoclonal antibody Trastuzumab/Herceptin is considered as frontline therapy for Her2-positive breast cancer patients. However, it is not effective against several patients due to acquired or de novo resistance. In last one decade, several assays have been performed to understand the mechanism of He...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967150/ https://www.ncbi.nlm.nih.gov/pubmed/24670875 http://dx.doi.org/10.1038/srep04483 |